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DOI: 10.1039/c0jm03863fMultifunctional iron oxide (FeOx) magnetic nanoparticles (MNPs) are promising items for biomedical
applications. They are studied as theranostic agents for cancer treatment, selective probes for
bioanalytical assays, controllable carriers for drug delivery and biocompatible tools for cell sorting or
tissue repair. Here we report a new method for the synthesis in water of FeOx–MNPs via a top-down
physical technique consisting in Laser Ablation Synthesis in Solution (LASiS). LASiS is a green
method that does not require chemicals or stabilizers, because nanoparticles are directly obtained in
water as a stable colloidal system. A gamut of characterization techniques was used for investigating
the structure of FeOx–MNPs that have a polycrystalline structure prevalently composed of magnetite
(ca. 75%) and hematite (ca. 22%). The FeOx–MNPs exhibit very good magnetic properties if compared
to what is usually reported for iron oxide nanoparticles, with saturation magnetization close to the bulk
value (ca. 80 emu g1) and typical signatures of the coexistence of ferrimagnetic and antiferromagnetic
phases in the same particle. The functionalization of FeOx–MNPs after the synthesis was possible with
a variety of ligands. In particular, we succeeded in the functionalization of FeOx–MNPs with
carboxylated phosphonates, fluorescent alkylamines, fluorescent isothiocyanates and bovine serum
albumin. Our FeOx–MNPs showed excellent biocompatibility. Multifunctional FeOx–MNPs were
exploited for macrophage cell labelling with fluorescent probes as well as for cell sorting and
manipulation by external magnetic fields.Introduction
Iron oxide (FeOx) magnetic nanoparticles (MNPs) find appli-
cations in several branches of technology like biomedicine,
environmental sciences, information storage, micromechanics
and microfluidics.1–3 In the field of nanomedicine there is
a growing interest due to the intrinsic multifunctionality of
MNPs.3,4 For example, they can be used as negative contrast
agents in magnetic resonance imaging (MRI)5,6 or for an imagingaDepartment of Chemical Sciences, University of Padova, via Marzolo 1,
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This journal is ª The Royal Society of Chemistry 2011technique with higher resolution called magnetic particle imaging
(MPI).7 MNPs are also studied as therapeutic agents for radio-
frequency magnetic field induced hyperthermia of malignant
tissues and for fast tissues cicatrization.4,8 Recently, a technique
for destroying cancer cells based on magnetic field induced
mechanical damage of functionalized magnetic discs was also
proposed.9 Moreover, MNPs can be directed to specific sites by
an external magnetic field for drug delivery and theranostic
purposes.4,10 Alternatively, they can be used for driving a distinct
object to a predetermined site, like in cell sorting and cell
manipulation as well as in toxin decorporation.3,4,10
Controlling the surface chemistry of MNPs is a crucial point
for introducing other functionalities. Stabilizing shells based on
stealth polymers or polysaccharides are useful for improving the
stability in physiological medium and for escaping the reticulo-
endothelial system, in order to allow targeting and diffusion in
remote parts of the body.4,5 Optical probes like fluorescent
molecules can be useful for improving the resolution of MRI and
can be used for intrasurgical imaging.11,12 Antibodies and other
targeting functionalities (e.g. folic acid) can confer high selec-
tivity to particle accumulation that cannot be obtained by
external magnetic fields.13–15 In recent years, however, effectiveJ. Mater. Chem.
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View Onlinetargeting of tissues for imaging or therapy was mainly obtained
by the enhanced permeation and retention (EPR) effect,3,6,14,16,17
by the preferential accumulation of magnetic nanoparticles in
Kupffer cells in the liver3,6 or by using the ability of macrophages
and stem cells in infiltrating deep tissues, with or without the
guide of an external magnetic field.5,16,18,19 In all cases, important
requirements are high biocompatibility, good magnetic proper-
ties, an average size above kidneys clearance threshold and
a surface chemistry allowing particles uptake in the desired
sites.3,4
Within the reported context, FeOx–MNPs offer some advan-
tages in comparison to other MNPs due to their good biocom-
patibility and long term biodegradability. The standard
preparation methods of FeOx–MNPs consist in a wet chemistry
bottom up approach in water or organic solvents.4,10 Due to the
assistance of stabilizers, wet chemistry methods allow a good
control of particles size and polydispersity at the nanometric
scale.4,10 Further functionalization or stabilization of particles is
possible by procedures like place exchange, silanization and in
situ or ex situ polymer encapsulation.4,10,20,21
However, wet chemistry methods can have some drawbacks.
Some approaches for the synthesis in organic solvents can
involve expensive chemicals (e.g. the organometallic precursors)
and can require high temperature and pressure, therefore they
cannot be considered as ‘‘green’’ methods.13,22,23 For biomedical
applications, nanoparticles must become hydrophilic by replac-
ing the hydrophobic shell.4,10,24 Some concerns about the
biocompatibility of FeOx particles obtained in organic solvents
also exist.10,22 On the other hand, the synthesis in water usually is
more problematic for the control of particle crystallinity versus
the amorphous fraction and for the selectivity of the oxide
phase.5,23 In order to obtain magnetite Fe3O4-MNPs with the
correct stoichiometry and, hopefully, with high crystallinity, the
solution must be kept under nitrogen or argon atmosphere
because of the fast oxidation of Fe(II) by atmospheric oxygen.25
Sometimes also high temperatures and pressures are required, as
in the hydrothermal synthesis.22,23,25,26 In most cases, the
synthesis of FeOx–MNPs with saturation magnetization of the
order of 50–65 emu g1 was reported, depending on particles size,
in contrast to a value of ca. 92 emu g1 for bulk magnetite.4
Lower values of saturation magnetization can be due to finite size
effects like spin canting,27,28 to the presence of a dead spin layer,29
and to amorphous phases or to oxide phases with inferior
magnetic properties like hematite (a-Fe2O3).
10,30
In recent years some efforts have been directed to obtain
FeOx–MNPs with higher saturation magnetization by environ-
mental friendly procedures.13,22,25,26,31 In particular, bacterial
production of FeOx–MNPs and flame synthesis showed to be
viable green techniques for obtaining nanoparticles with high
saturation magnetization, but there are some problems for
particles functionalization and dispersion.22,32,33
Here we report about a top-down approach for the synthesis of
FeOx–MNPs by a physical method called Laser Ablation
Synthesis in Solution (LASiS), consisting in the laser ablation of
a bulk iron target in aqueous solution. The so obtained FeOx–
MNPs form a colloidal system that is stable in water for a long
time even in the absence of stabilizers. Moreover, LASiS is
a green approach to the synthesis of nanomaterials and requires
limited manual operation.34 In the present work, using a gamutJ. Mater. Chem.of complementary characterization techniques, we demonstrate
that our synthetic procedure originates polycrystalline ultrasmall
FeOx–MNPs, prevalently composed of magnetite (ca. 75%)
showing a saturation magnetization comparable to the bulk one
(ca. 80 emu g1). Moreover, the functionalization of FeOx–
MNPs was possible by straightforward procedures with a variety
of ligands like fluorescent alkylamines, fluorescent iso-
thiocyanates, bovine serum albumin and stabilizing carboxylated
phosphonates. In particular, the multifunctionalization of
FeOx–MNPs by sequential addition of ligands was demon-
strated by using two different coordinating functionalities bound
to two different fluorescent probes.
Our multifunctional FeOx–MNPs were used for fluorescent
labelling of macrophage cells and for cell sorting and cell
manipulation studies by external magnetic fields with high effi-
ciency. Magneto-fluorescent macrophage cells are of great
interest in nanomedicine because they can act as carriers of
MNPs into deep lesions, aiming at the multimodal magnetic
resonance–fluorescence imaging and at magnetic field induced
hyperthermia.
Experimental methods
Synthetic procedure
FeOx–MNPs were obtained by Laser Ablation Synthesis in
Solution (LASiS), by a procedure similar to what previously
reported.34–36 Briefly, laser ablation was obtained with Nd:YAG
(Quantel YG981E) laser pulses at 1064 nm (9 ns) focused with
a 10 cm focus lens on a 99.99% pure iron plate placed at the bottom
of a cell containing bidistilled water. Pulses of 10 J cm2 at a 10 Hz
repetition rate for 90 min were employed. Disodium ethylenedi-
aminetetraacetate (>98%, Sigma Aldrich) was added with a 5 mM
final concentration to the so obtained FeOx–MNPs solution and
heated at 55 C for 600. Particles were washed multiple times with
bi-distilled water by centrifugation at 5000 rpm.
Structural characterization
For transmission electron microscopy (TEM) we collected the
images at 300 kV with a JEOL JEM 3010 microscope equipped
with a Gatan Multiscan CCD Camera model 794. The samples
for TEM analysis were prepared by evaporating FeOx–MNPs
suspension on a copper grid covered with a holey amorphous
carbon film. The micro-Raman measurements were recorded by
focusing the 5 objective of a Renishaw inVia micro-Raman
instrument on a dried powder of FeOx–MNPs using the 633 nm
line of an He–Ne laser with an output power of 0.75 mW. At high
laser power the oxidation of magnetite to hematite was observed.
For UV-visible spectroscopy we used a Varian Cary 5 spec-
trometer and 2 mm optical path quartz cells. FTIR measure-
ments were recorded in attenuated total refraction (ATR)
configuration on a Ge head with a Nicolet 5700 spectropho-
tometer on dried FeOx–MNP powders. DLS measurements were
performed with a SpectraPhysics Nicomp 380 instrument
(Particle Sizing Systems, Santa Barbara, CA) equipped with
a 633 nm He–Ne laser. We reported the number weighted size
distribution and relative standard deviation because the results
were in good agreement with what observed by TEM analysis on
the same samples.This journal is ª The Royal Society of Chemistry 2011
D
ow
nl
oa
de
d 
on
 0
1 
Fe
br
ua
ry
 2
01
1
Pu
bl
ish
ed
 o
n 
31
 Ja
nu
ar
y 
20
11
 o
n 
ht
tp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C0
JM
038
63F
View OnlineA Philips diffractometer was employed to collect the XRD
patterns. The setup is constituted by an X’Pert vertical goni-
ometer with Bragg–Brentano geometry, a focusing graphite
monochromator and a proportional counter with a pulse-height
discriminator and it is connected to a highly stabilized generator.
Nickel-filtered Cu Ka radiation and a step-by-step technique are
employed (steps of 2q ¼ 0.05), with collection times of 30 s per
step. Line broadening analysis (LBA) was carried out using
a previously published method.37 The quantitative phase analysis
by X-ray diffraction was performed using the Rietveld method
(DBWS9600 computer program written by Sakthivel and Young
and modified by Riello et al.)38 and according to the following
PDF files: Fe Pdf: 87-722; FeO Pdf: 75-1550; Fe2O3 Pdf: 33-664;
Fe3O4 Pdf: 89-688. The Fe peak corresponds to particles with
a size of ca. 60 nm as obtained by the Debye–Scherrer formula
that were not observed in TEM images.
For XPS measurements, a droplet of a solution containing the
FeOx–MNPs has been let dry off on a roughened tantalum sample
holder until obtaining a very thin homogeneous film. The surface
composition of the FeOx–MNP powders was analyzed by XPS
using a modified VG ESCALAB MKII (Vacuum generators,
Hastings, England) equipped with a twin (Mg/Al) anode X-ray
source, a sputter gun, and a hemispherical electrostatic analyzer
with a five channel detector. The XPS data reported in the present
study were obtained using Al-Ka radiation (1486.6 eV) as an
excitation source. Photoemission spectra have been obtained at
room temperature using a normal emission geometry. Prior to
measurements, the samples were degassed overnight in the anal-
ysis chamber (pressure lower than 108 mbar).
For fluorescence analysis we used a Perkin Elmer LS50B
luminescence spectrometer and 1 cm quartz cells.
The Fe content in our samples was determined by inductively
coupled plasma-mass spectrometry (ICP-MS) measurements
carried out with a Thermo Elemental X7 Series instrument
equipped with the PlasmaLab software package. For instrument
calibration, a standard Fe solution was purchased from Spec-
trascan. The iron concentration of a series of reference solutions
was determined by ICP-MS and then correlated to the absorp-
tion spectrum of these solutions.
Magnetic characterization
The magnetic properties of these samples were investigated both
in solution and as dry powder using a Cryogenic S600 SQUID
magnetometer; Zero-field-cooled (ZFC) magnetizations were
measured by cooling samples in zero magnetic field and then by
increasing the temperature in an applied field of 50 Oe, while
field-cooled (FC) curves were recorded by cooling the samples in
the same probe field. The field dependence of the magnetization
(hysteresis loop) was recorded up to 50 or 65 kOe at T ¼ 2.5
K. When possible the saturation magnetization (Ms) was derived
from a plot of M versus 1/H, extrapolating the M values for 1/H
/ 0. The content of iron in sample solutions was determined by
ICP-MS analysis on aliquots of the same solutions used for the
measurements.
Functionalization
Functionalization by adding the ligands after the synthetic
procedure consisted in the addition of a 0.01% in weight aqueousThis journal is ª The Royal Society of Chemistry 2011solution of BSA or F-BSA (Fatty Acid Free Bovine Serum
Albumin or Albumin–fluorescein isothiocyanate conjugate from
Sigma Aldrich) and 0.005% aqueous solutions of F–PEG–NH2
(Fluorescein–PEG–Amine, Mw 5000, from Lysan Bio), FITC
(fluorescein isothiocyanate mixed isomers from Sigma Aldrich),
TRITC (Tetramethylrhodamine isothiocyanate mixed isomers
from Sigma Aldrich) or PMIDA (N-phosphonomethyl imino-
diacetic acid hydrate from Sigma Aldrich) to an equal volume of
FeOx–MNPs in water (0.5 mg per ml iron). We tested various pH
conditions by incubating the FeOx–MNPs with the ligands at
acidic (pH 4) or basic (pH 9) conditions and we found that the
best conjugation efficiency was obtained in acidic pH. This is
likely due to the good stability of FeOx–MNPs observed at acidic
pH, as proved also by DLS measurements. In order to prevent
the adsorption of carboxylic or phosphate molecules on particles
surface, the pH was set by adding controlled amounts of very
diluted HCl or NaOH solutions. After 24 hours of incubation at
room temperature, the solutions were washed at least twice by
centrifugation at 5000 rpm with bidistilled water and twice with
5 mM PBS solution.Cell labelling and manipulation
U937 cells were obtained from the American Type Culture
Collection (ATCC) and maintained according to ATCC proto-
cols. The human non-adherent monocyte-like U937 cells were
differentiated into macrophages by a 48 hour exposure to PMA
(phorbol 12-myristate 13-acetate, Sigma-Aldrich) at a concen-
tration of 40 nM. At day 0 cells were seeded at 0.5  106 cells per
well in a 6 well plate and treated with PMA; after 48 hours the
medium was changed and the cells resuspended in complete
medium without PMA. At day 3 the uptake experiments were
performed; briefly, cells were incubated in complete medium at
37 C for 4 hours with F–PEG–NH2/FeOx–MNPs equivalent to
a final concentration of 0.36 mg per ml of iron. A mock-treated
control well was also prepared. For flow cytometry analysis, each
well was washed four times with PBS at the end of the incubation
period to eliminate the non-internalized FeOx–MNP; adherent
cells were detached with the trypsin/EDTA solution and washed
three times with PBS. Two samples, one of FeOx–MNPs treated
and one of non-treated cells, were also stained for 30 minutes at
0 C with APC anti-human CD13 (BD Biosciences Pharmingen,
NY, US) and washed three times with ice cold PBS. CD13-
stained and non-stained cells were analyzed using a BD FACS-
Canto cytometer; an aliquot of analyzed cells were used in the
magnetic cell sorting experiments. Magnetic separation of FeOx–
MNP tracked cells was performed at 4 C; after a 10 minute
exposure to a magnetic field non-attracted cells were washed out.
Magnetic sorted and non-attracted cells were re-analyzed by flow
cytometry.
For confocal microscopy analysis U937 cells seeded in a 24
well plate on polylysine coated glass slides were differentiated
into macrophages and were treated with FeOx–MNPs as previ-
ously described. After washing of non-internalized FeOx–MNPs,
cells were fixed in 2% paraformaldehyde, washed four times with
PBS and stained with APC anti-human CD13. Glass slides were
washed in PBS and mounted for confocal microscopy analysis
(Zeiss LSM 510 confocal microscope).J. Mater. Chem.
Fig. 1 TEM images of FeOx–MNPs. The particle size is in the 5–30 nm
range (a) with a log-normal size distribution, as reported in the histogram
(b), with an average of 10 nm and a standard deviation of 6 nm. The
HRTEM image (c) shows a polycrystalline structure. We measured
interplanar distances of 0.25 nm that matches with magnetite/maghemite
(311) or hematite (110), and of 0.48 nm that matches with magnetite/
maghemite (111) planes.
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View OnlineCell viability after FeOx–MNPs incorporation was evaluated
by the XTT assay. Briefly, U937 differentiated cells were
obtained according to the above described protocol and treated
with FeOx–MNPs at 37 C for 4 hours at a final iron concen-
tration of 0.18, 0.36 and 0.72 mg ml1. Then, the cells were
washed to remove FeOx–MNPs and the medium was replaced.
After 20 hours, the cell viability was measured with an XTT
assay.
Cell apoptosis was assessed by the human Annexin V-FITC
Kit (Bender MedSystems, Wien, Austria). Cells were incubated
with FeOx–MNPs at 37 C for 4 hours (iron concentration of
0.36 mg ml1), then washed to remove excess FeOx–MNPs and
the medium was replaced. After 2 h and 20 h, cells were treated
with the human Annexin V-FITC Kit and analysed with flow
cytometry.Results and discussion
Synthesis and characterization
FeOx–MNPs were obtained by a top-down physical method
consisting in the Laser Ablation Synthesis in Solution (LASiS) of
a bulk iron (99.99%) target in water. LASiS is a straightforward
procedure that requires a simple experimental setup and can be
applied to the synthesis of a variety of nanostructured materials
by operating minor changes in the experimental conditions.34
The synthesis of FeOx–MNPs by LASiS in water mimics the
procedure successfully applied to the synthesis of noble metal
nanoparticles in similar conditions.34–36,39,40 Laser ablation was
carried out with laser pulses at 1064 nm (9 ns, 10 Hz, 10 J cm2) of
a Nd:YAG laser focused on a pure iron plate placed at the
bottom of a cell containing bidistilled water. Except bulk iron
and water, no other chemicals or stabilizers are required by
LASiS. By ICP-MS analysis, we quantified the yield of FeOx–
MNPs obtained by LASiS in about 1 mg per 80 000 laser pulses
at 1064 nm (9 ns, 10 J cm2). These figures correspond to 0.45 mg
h1 at 10 Hz and 45 mg h1 at 1 kHz, therefore LASiS of FeOx–
MNPs has the potential to be scaled up to gram scale synthesis by
optimizing the experimental setup and the ablation parameters,
in order to obtain synthetic yields comparable to other methods
like chemical reduction or spray pyrolysis.
Transmission electron microscope (TEM) analysis showed
that FeOx–MNPs have sizes in the 5–30 nm range with a log-
normal size distribution, an average size of 10  6 nm and a well
defined spherical shape (Fig. 1a and b). High resolution TEM
(HRTEM) analysis clearly evidenced the polycrystalline
structure of the nanoparticles, with crystallite size on the order
of 3–5 nm (Fig. 1c). This finding is in agreement with nano-
particle formation mechanism usually observed with LASiS,
consisting in the nucleation of small embryos followed by their
coalescence into larger particles.34 The HRTEM analysis
evidenced the formation of nanocrystals with prevailing crys-
talline interplanar distances of 0.25 nm and 0.48 nm (Fig. 1c).
Within the experimental error, these distances are compatible
with iron oxide phases like magnetite or maghemite (0.25 and
0.48 nm for (311) and (111) planes respectively) and hematite
(0.25 nm for (110) planes), but not with metallic iron (0.20 nm
for (110) planes).30 This is in agreement with what expected,
because the ablation process produces a plasma plume rich ofJ. Mater. Chem.iron atoms coming from the target as well as of reactive oxygen
species coming from the water solution.34 Due to the poly-
crystalline structure and to the fast formation kinetics of FeOx–
MNPs, grain boundaries are highly defective, though no
amorphous domains are observed inside the particles. We also
found that LASiS produced a fraction of amorphous material
present as a network with micrometric size, probably due to
iron hydrates. For this reason, the FeOx–MNPs solution
obtained by LASiS were washed with 5 mM disodium ethyl-
enediaminetetraacetate (EDTA) at 55 C for 600 in order to
selectively remove the amorphous fraction, according to a well
established procedure.41
The determination of the iron oxide phases composing the
FeOx–MNPs is not a straightforward task, because some oxide
phases have similar structural parameters but not necessarily
identical magnetic properties.30 Therefore we used a series of
investigation techniques that provided complementary infor-
mation about nanoparticles composition.
Raman spectroscopy is useful for the identification of the iron
oxide phase because magnetite, maghemite and hematite have
different Raman active vibrational fingerprints, although the
Raman bands proper to FeOx phases may not always
be observed when crystalline grains have sizes of the order of
3–5 nm.42,43 In our case, the spectrum collected on a dried FeOx–
MNPs sample with the 633 nm He–Ne laser line of a micro-
Raman spectrometer (Fig. 2a) shows one peak at 670 cm1 that
matches with the Raman spectrum of magnetite reported in the
literature. Since no traces are present from other bands like those
proper to maghemite or hematite, one can suppose that magne-
tite is the prevailing phase in our sample.42
UV-visible spectroscopy can be useful for identifying iron
oxide phases because only magnetite shows a broad absorption
band in the near infrared region due to intervalence charge
transfer transitions.44 The UV-visible spectrum of FeOx–MNPs
in water solution (Fig. 2b) clearly shows a band at wavelengths
longer than 800 nm that is proper to magnetite and a more
intense absorption edge at shorter wavelengths that is not
distinctive of the iron oxide phase.44
Fourier transformed infrared (FTIR) spectroscopy is useful
for evidencing the presence of magnetite and maghemite in the
FeOx–MNPs sample, because maghemite is characterized by
a peak close to 600 cm1, while magnetite has a strong IRThis journal is ª The Royal Society of Chemistry 2011
Fig. 2 (a) Raman spectrum on dried FeOx–MNPs showing a sharp peak
at 670 cm1 and a weak band at 540 cm1 typical of magnetite. (b) UV-
visible spectrum of FeOx–MNPs solution after the synthetic procedure
showing the absorption edge at small wavelengths proper to iron oxides
and the large absorption band over 800 nm characteristic of magnetite.
The inset shows a magnification of the absorption band in the near
infrared range. (c) ATR–FTIR spectrum of dried FeOx–MNP powders
showing a sharp absorption band at 570 cm1 proper to magnetite, while
no other bands are observed, indicating that no other contaminants are
present in the sample. (d) Powder XRD analysis of FeOx–MNPs (black
line) and Rietveld fitting (red line). Magnetite is the prevailing component
(ca. 75%), with ca. 22% of hematite, ca. 2% of wuestite and ca. 1% of
metallic iron. (e and f) XPS data (Al-Ka) in the Fe 2p and O 1s regions
collected on a FeOx–MNPs sample (black line) and on commercial 5 mm
magnetite particles (red line).
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View Onlineabsorption band at 570 cm1.10,45–48 In the present case, the FTIR
spectrum (Fig. 2c) is dominated by the absorption band of
magnetite at 570 cm1, while a shoulder is observed at longer
wavenumbers that can be attributed to traces of maghemite or to
defective FeOx phases like nanostructured hematite.10,45–49 As
a further confirmation, we observed the same band at 570 cm1
also in the spectrum of a reference commercial magnetite sample
(5 mm particles). The FTIR spectrum has been collected in the
whole analysis range of 500–4000 cm1 allowed by the Ge head in
the ATR configuration, to show that no vibrations ascribable to
organic contaminants are present. This finding confirms that our
synthetic procedure based on LASiS allows the synthesis of
FeOx–MNPs that are free of chemical by-products.
X-Ray diffraction (XRD) was performed on FeOx–MNPs for
obtaining a complete identification of the phases composing the
particles (Fig. 2d). The reflections of magnetite and maghemite
cannot be easily discriminated by XRD.30,50 However, the results
of the previous characterization techniques indicated that
magnetite should be the prevailing phase in our samples. By the
Rietveld analysis of the spectrum, we evaluated that the cubic
spinel phase ascribable to the magnetite Fe3O4 is the prevailing
phase (75% in weight), with a fraction of hematite a-Fe2O3
(22%), traces of wuestite FeO (2%) and iron Fe (1%). The
Rietveld analysis indicated that crystalline domains are 3–5 nm
in size, in agreement with the polycrystalline structure observed
by HRTEM. The refined lattice parameter of the spinel phase is
0.8382  0.0006 nm, closer to the magnetite than to the
maghemite cell (0.8396 and 0.8352 respectively), in agreementThis journal is ª The Royal Society of Chemistry 2011with the other experimental evidence that the FeOx–MNPs are
composed of magnetite.
Since surface chemical properties of the FeOx–MNPs are
important for the successive functionalization, X-ray photo-
electron spectroscopy (XPS) measurements were performed in
order to obtain information about the surface composition. In
Fig. 2d and e we report the Fe 2p and O 1s XPS regions collected
on our FeOx–MNPs, together with the corresponding data of
a reference commercial magnetite sample (5 mm particles). The
Fe 2p photoemission line (Fig. 2d) measured on the FeOx–MNPs
presents broader features with respect to the commercial
magnetite standard: even if the overall shape and energy position
(Fe 2p3/2 maximum at 711 eV) of the two spectra are very similar,
one can observe that, in the case of the spectrum of the FeOx–
NPs, the full width at half maximum (FWHM) of the peaks is
larger (5 eV vs. 4 eV) and the distinctive satellite at 8.5 eV from
the main 2p3/2 peak, typical of stoichiometric magnetite, is
missing.51 These findings suggest that the surface of our FeOx–
MNPs is composed by a mixture of FeOx phases beside to the
prevalent magnetite that explains the slight broadening of the
main photoemission line on the low energy side and the absence
of a sharp satellite, and of Fe2O3 and hydroxide FeOOH, which
determines the slight enlargement of the photoemission peak on
the high energy slope. On the other hand, there is no indication of
the presence of metal Fe in the surface region probed by
photoemission (5 nm). In the case of the O 1s photoemission
line (Fig. 2e), both samples show rather broad spectra: the results
of a fitting procedure (reported in Fig. 2e) clearly indicate the
presence of a peak at 530.3 eV distinctive of lattice oxygen in iron
oxides, and two other peaks, at 532.0 eV and 533.5 eV respec-
tively, which are compatible with the presence of different kinds
of hydroxyls.52 Therefore, the surface and the interfaces of the
FeOx–MNPs are hydroxylated and strongly interacting with
water. The hydroxylated surface of FeOx–MNPs contributes to
their stability in bidistilled water during and after the laser
ablation synthesis.Magnetic characterization
The strong magnetic character of FeOx–MNPs can be qualita-
tively evidenced by simply placing a NdFeB magnet in proximity
of the solutions for overnight: as shown in Fig. 3a, the particles
respond to the applied field gradient. The magnetic properties of
the sample were quantitatively investigated both in solution and
as dry powders. Zero field cooling/field cooling (ZFC/FC)
magnetization curves measured with a field of 50 Oe (Fig. 3b)
indicated that thermal irreversibility starts to develop at
temperatures larger than the room temperature and that a large
distribution of energy barrier for the magnetization reversal
occurs, as indeed expected on the basis of size distribution
observed by TEM. The comparison of measurements carried out
on liquid solutions and on dry powders did not evidence any
relevant difference, therefore suggesting that dipolar interactions
amongst particles are negligible. It is worthwhile to note that no
evidence of the Verwey transition, characteristic of magnetite, is
observed in the investigated temperature range. This is an
orthorhombic to cubic structural transition occurring at ca. 120–
125 K which is expected to produce a sharp increase of the
magnetic moment.53 Possibly, the absence of the VerweyJ. Mater. Chem.
Fig. 3 Magnetic characterization of FeOx–MNPs: (a) the migration of FeOx–MNPs after overnight application of NdFeB magnets is shown in the
figure; (b) temperature dependence of the ZFC/FC magnetization under H ¼ 50 Oe measured for the solution (filled symbols) and dry powder (open
symbols); the measurements of the solution was stopped at 265 K to avoid the melting of the solution. (c) ZFC hysteresis cycle at 2.5 K; (d) magnification
of the hysteresis cycles carried out at 2.5 K after zero field cooling (ZFC—red hollow circles) and cooling in a 5 T magnetic field (FC5T—black squares);
the two curves were normalized to the saturation values obtained as described in the text.
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View Onlinesignature can be ascribed to the very small size of the actual
crystalline domains. Indeed it is known that at the nanoscale,
below ca. 50 nm, the transition temperature is size dependent,
strongly decreasing with the average size, and can even not be
observed in the case of particles with a size of the order of 5 nm or
less.54
According to ZFC/FC measurements, non-zero coercivity (30
Oe) and low reduced remnant magnetization, M0/M50kOe (0.02),
are observed in the hysteresis loop at room temperature, meaning
that a fraction of FeOx–MNPs are still blocked. This can be due
to a large magnetic anisotropy due to the exchange interactions
between the magnetic Fe3O4 and the antiferromagnetic a-Fe2O3
nanodomains that are present in our FeOx–MNPs, as indicated
by XRD analysis. However, another reason could be the pres-
ence of large nanoparticles in the tail of the size distribution
measured by TEM analysis. In any case, this feature can be of
interest for applications like magnetic hyperthermia induced by
alternate magnetic fields because both the hysteresis loss and the
reorientation heating mechanisms can be activated, by tuning the
applied frequency.8,55
In order to inquire the presence of exchange anisotropy due to
the coexistence of magnetic and antiferromagnetic domains in
close proximity, hysteresis cycles at low temperature (2.5 K) were
carried out after the sample was cooled down in zero field (ZFC)
or in a 5 T static field (FC5T) (Fig. 3c and d). In both loops the
sample magnetization did not reach saturation, due to surface
spin canting and/or to the presence of antiferromagnetic
domains. The saturation magnetization was evaluated by
extrapolating the M values for 1/H / 0 and was found to be
110.5 emu g1 of total iron. Taking into account the composition
as obtained from Rietveld analysis of X-ray pattern, this value
corresponds to ca. 80 emu g1 for our FeOx–MNPs. This value is
remarkably high for iron oxide nanoparticles, suggesting a highJ. Mater. Chem.crystalline quality of the synthesized nanomaterials. Large
magnetization is important for the application of MNPs in cell
sorting and cell manipulation, in magnetic induction hyper-
thermia, in MPI, but it is also of paramount importance for the
use of MNPs as MRI contrast agents because the spin–spin
relaxation time depends on the magnetic moment of nano-
particles.5,8,56 The coercive field observed in the ZFC loop is ca.
500 Oe which is what commonly observed for magnetite nano-
particles. The reduced remnant magnetization is 0.10, a value
much lower than that expected for an assembly of blocked single
domain FeOx–MNPs (0.5 or 0.66 for uniaxial or cubic magnetic
anisotropy, respectively),57 pointing out the presence of an
antiferromagnetic non-saturated phase (hematite) and the poly-
crystalline character of the sample. As shown in Fig. 3d, the
FC5T hysteresis cycle is significantly shifted to negative fields,
and presents a larger coercive field and remnant magnetization
than the ZFC cycle: the shift evaluated as the half-sum between
the positive and negative coercivities is 200 Oe, the average
coercive field is 580 Oe and the reduced remanences are 0.23 and
0.14 for positive and negative magnetizations, respectively. Such
behaviour is characteristic of exchange bias systems where
ferrimagnetic/antiferromagnetic interfaces occur, and therefore
well agree with the presence of magnetite and hematite nano-
domains in the same polycrystalline nanoparticle.FeOx–MNPs functionalization
Functionalization of FeOx–MNPs obtained by LASiS can occur
by inserting the ligands after the synthesis because the surface
charge of the colloidal system prevents particles aggregation
without the need for interfering stabilizing molecules, similarly to
what reported for noble metal nanoparticles obtained by
LASiS.34–36This journal is ª The Royal Society of Chemistry 2011
Fig. 4 (a) UV-visible spectra of non-functionalized FeOx–MNPs (black
line), FeOx–MNPs conjugated with F-BSA (red line) and F–PEG–NH2
(green line). The absorption band of fluorescein at 490 nm is evident in
both cases. The dotted green lines are the corresponding fluorescence
spectra. (b) UV-visible spectra of non-functionalized FeOx–MNPs (black
line), FeOx–MNPs conjugated with FITC (green line) and TRITC (red
line) with the relative fluorescence emission spectra (dotted lines). The
absorption bands of fluorescein at 490 nm and of rhodamine at 560 nm
are evident in both cases. (c) UV-visible (straight lines) and fluorescence
(dotted lines, excitation at 460 nm or 530 nm) spectra of FeOx–MNPs
after sequential functionalization with F-BSA and TRITC (red lines) or
with F–PEG–NH2 and TRITC (green lines). (d) Average size and relative
standard deviation of FeOx–MNPs at pH 4 and in PBS solutions
measured by DLS.
D
ow
nl
oa
de
d 
on
 0
1 
Fe
br
ua
ry
 2
01
1
Pu
bl
ish
ed
 o
n 
31
 Ja
nu
ar
y 
20
11
 o
n 
ht
tp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C0
JM
038
63F
View OnlineThe feasibility of MNPs conjugation after the synthetic
procedure was investigated by using four different types of
molecules composed by a coordination function and an optical
active moiety. The molecules are fluorescein-bovine serum
albumin (F-BSA), amine terminated fluorescein-poly-
ethyleneglycol (F–PEG–NH2) and fluorescein or tetrame-
thylrhodamine isothiocyanate (FITC or TRITC) and with an
effective stabilizer for physiological environments like N-phos-
phonomethyl iminodiacetic acid (PMIDA).58 The functionali-
zation procedure consisted in the incubation of the FeOx–MNPs
at room temperature for 24 hours with the ligand solutions. By
UV-visible and fluorescence spectroscopy, we tested conjugation
both in acidic (pH 4) and basic (pH 9) conditions but we
generally observed better conjugation efficiency after incubation
at acidic pH. This finding can be the effect of the good dispersion
of FeOx–MNPs at pH 4, in contrast with the trend to agglom-
eration observed at pH 9 that is characteristic of iron oxides in
aqueous solutions.4 After the incubation, excess ligands were
washed multiple times with water and with phosphate buffer
saline (PBS) solutions by centrifugation. We washed the func-
tionalised FeOx–MNPs with PBS because it is well known in the
literature that weakly bound ligands are readily displaced from
the surface of iron oxide nanoparticles in physiological medium
by phosphate groups.3,4,11,12 Therefore, we are confident that only
strongly bound ligands overcame our washing procedures with
PBS.
BSA can be seen as a polydentate and polyfunctional ligand
capable of coordinating FeOx–MNPs by carboxylic groups and
amine groups.59,60 UV-visible and fluorescence spectroscopy
provided clear indications of the presence of F-BSA coating on
FeOx–MNPs after the washing procedure (Fig. 4a). By exploit-
ing the intense absorption of the fluorescein moiety in F-BSA
(according to the datasheet of the F-BSA, 10 fluorescein mole-
cules are present on average per BSA molecule) we evaluated that
2.3 nanomoles of F-BSA per mg of Fe were present after the
purification step. Further confirmation of the coating of FeOx–
MNPs with BSA was obtained by FTIR measurements that
allowed the detection of the two intense Amide I and Amide II
bands centered at approximately 1660 and 1550 cm1 charac-
teristic of albumin (see Fig. S1a in the ESI†).59,60
Alkylamines have been frequently used for the stabilization of
FeOx–MNPs in aqueous solution,4 hence we tested the conju-
gation of FeOx–MNPs with a fluorescent alkylamine like
F–PEG–NH2. Similarly to what observed for BSA, we found
that FeOx–MNPs were efficiently coated by F–PEG–NH2, as
assessed by UV-visible and fluorescence spectroscopy (Fig. 4a)
and by FTIR analysis, where we detected the C–O stretching
bands in the 1100–1000 cm1 range (see Fig. S1b in the ESI†). By
UV-visible spectroscopy, we evaluated that 20.6 nanomoles of
F–PEG–NH2 per mg of Fe were present after the purification
step.
Isothiocyanates can undergo a slow reaction with nucleophilic
oxygen atoms like those present on the surface of hydroxylated
iron oxide nanoparticles,10,61 hence the NCS group can be an
alternative to other ligands based on ammonium, carboxylic or
phosphonate groups that prevalently coordinate surface metal
atoms. However, at pH 4, this reaction is not favoured. On the
other hand, the thiocyanate group is well known for its coordi-
nating ability of metal ions that offer a second opportunity forThis journal is ª The Royal Society of Chemistry 2011the binding of FITC and TRITC to the surface of FeOx–MNPs.
In fact, the successful coating of FeOx–MNPs with FITC and
TRITC was assessed by UV-visible and fluorescence spectros-
copy (as can be clearly seen in Fig. 4b). By UV-visible spec-
troscopy, we evaluated that ca. 12.9 nanomoles of FITC/TRITC
per mg of Fe were present after the purification step.
Since ligands are added to FeOx–MNPs after the synthetic
procedure, the multifunctionalization with molecules bearing
different coordinating ends is possible. We verified the feasibility
of the multifuctionalization by the sequential coordination of F-
BSA/FeOx–MNPs and F–PEG–NH2/FeOx–MNPs with
TRITC, exploiting the different site selectivity of these ligands.
In order to avoid the eventuality of FeOx–MNPs surface satu-
ration with phosphate from the PBS solution, the intermediate
products consisting of F-BSA/FeOx–MNPs and F–PEG–NH2/
FeOx–MNPs were obtained by washing excess F-BSA and F–
PEG–NH2 with bidistilled water instead of PBS and then
restoring the pH 4 after washing. Both the UV-visible and the
fluorescence analysis confirmed that the sequential multi-
functionalization successfully occurred (Fig. 4c). This finding can
be indicative that the isothiocyanate derivatives followed
a different coordinating path with respect to the amine derivative
and to BSA, as discussed above.
Coordination of FeOx–MNPs with PMIDA takes place
readily due to the high affinity of phosphate groups with iron
oxides, as was confirmed by the FTIR spectrum of conjugated
FeOx–MNPs (see Fig. S1c in the ESI†). The two carboxylic
groups present in the PMIDA molecule confer high stability toJ. Mater. Chem.
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View OnlineFeOx–MNPs in PBS medium and offer the opportunity for their
bioconjugation by reaction with amines after activation of
carboxylic groups, as reported in the valuable work of Das and
coworkers.58 We verified the excellent time stability of PMIDA
coated FeOx–MNPs in PBS by dynamic light scattering (DLS)
measurements. The aggregation of FeOx–MNPs in physiological
medium is a well known phenomenon observed also in some
commercially available ultrasmall superparamagnetic iron oxide
particles that conflicts with the real applicability of MNPs in vivo.
By DLS analysis we observed that the average size of unpro-
tected FeOx–MNPs at pH 4 is of 26 nm, while the same particles
after 24 hours in PBS have an average size of 94 nm (Fig. 4d).
Similar results were found for FeOx–MNPs coated with F-BSA,
F–PEG–NH2, FITC or TRITC. On the contrary, by performing
the DLS measurement on PMIDA/FeOx–MNPs we found an
average size of 20 nm at pH 4 as well as in PBS solution. The
values measured by DLS were in close agreement with what
observed by TEM on the same samples. These results may be
indicative that a complete coating of particles surface and
a modification of FeOx–MNPs surface charges were achieved
only in the case of PMIDA/FeOx–MNPs. This is a confirmation
of the superior conjugation ability of phosphate groups in
comparison to other ligands, and that the stabilization mecha-
nism of PMIDA in PBS, based on the electrostatic repulsion due
to the de-protonation of the carboxylic ends in basic environ-
ment, is much more efficient in comparison to the other ligands.
We also found that FeOx–MNPs are stable in PBS solution
when in the presence of sodium dodecyl sulfate (SDS) at
a concentration lower than the critical micellar concentration. In
this case the average size obtained by DLS analysis was ca. 30
nm. This is especially interesting when functionalization of
FeOx–MNPs by silanization or polymer encapsulation in
aqueous solution is desired.4,10 Therefore, the functionalizationFig. 5 Two representative confocal microscope images of macrophages afte
APC. (a) FITC fluorescence channel only; (b) merged images of aCD13–AP
FITC-labelled MNPs and staining with aCD13–APC, were separated by a ma
the sorting experiments. (c) Cytofluorimetric analysis of macrophages showin
analysed; (d) cytofluorimetric analysis of positively sorted cells.
J. Mater. Chem.of FeOx–MNPs obtained by LASiS can take place also with the
same methods previously reported for iron oxide nanoparticles
obtained by wet chemistry synthesis.Macrophage labelling and manipulation
Since FeOx–MNPs with size in the range of tens to hundreds of
nanometres are readily uptaken by macrophages cells, have
a strong magnetic response and are efficient heaters for magnetic
hyperthermia,3–5,8,10 we tested the capability of FeOx–MNPs to
be uptaken by macrophage cells. Macrophages have the ability of
infiltrating and accumulating in a variety of lesions like wounds,
atherosclerosis plaques and deep cancerous tissues that are not
reachable by EPR effects.4,16–18,62 Therefore, macrophage cells
can act as efficient and selective carriers of multifunctional
FeOx–MNPs to the desired sites for a variety of applications like,
for instance, wound cicatrization or cancer therapy by magnetic
hyperthermia.4 Moreover, fluorescent FeOx–MNPs can be used
for the multimodal imaging of lesions by magnetic resonance and
fluorescence imaging,3,5,11,62 that is useful because MRI has
a relatively low spatial resolution and cannot be used in the
intrasurgical stage, contrary to fluorescence.3,5,11,62
While the loading of cells with MNPs has been frequently
reported in the literature,63 the loading of macrophage cells with
magneto-fluorescent particles is less frequent. In our experi-
ments, fluorescein conjugated FeOx–MNPs (F–PEG–NH2/
MNPs) were first incubated with U937 cells, differentiated into
macrophages by exposure to PMA, at 37 C for 4 hours and then
thoroughly washed in order to remove excess particles (see the
Experimental methods for details). After incubation and washing
procedures, we assayed the uptake of particles by flow cytometry
and confocal microscopy (Fig. 5). A clear fluorescence signal due
to the fluorescein adsorbed on FeOx–MNPs was detected in bothr incubation with F–PEG–NH2/FeOx–MNPs and staining with aCD13–
C and FITC fluorescence channels. Macrophages, after incubation with
gnet. Cells were then analyzed by flow cytometry before (c) and after (d)
g efficient phagocytosis of fluorescent MNPs (FITC labelled) by all cells
This journal is ª The Royal Society of Chemistry 2011
Fig. 6 a) XTT assay of cell viability: U937 differentiated cells were incubated for 4 h at 37 C with FeOx–MNPs at an iron concentration of 0.18, 0.36
and 0.72 mg ml1 and the cell viability was measured after 20 h. Evaluation of cell apoptosis: U937 differentiated cells were incubated for 4 h at 37 C
with FeOx–MNPs; then cell apoptosis was assessed after 20 h by flow cytometry using the human Annexin V protocol (b: U937 untreated cells, c: FeOx–
MNPs treated cells; d: Taxol treated cells used as positive control of apoptosis).
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View Onlinecases (Fig. 5). Moreover, macrophage cells were stained with
antiCD13–APC labelled antibody that is a marker selective for
the membrane of macrophage cells and provides a good contrast
for the visualization of cell walls. Confocal microscopy analysis
emphasized that fluorescence from fluorescein is observed in the
central part of the cells, as expected after phagocytosis of parti-
cles, while the CD13–APC signal is collected principally from the
cell walls as expected for this type of label (Fig. 5a and b). Flow
cytometry indicated that more than 95% of macrophage cells had
a magnetic-fluorescent payload after incubation with F–PEG–
NH2/MNPs (Fig. 5c).
Macrophage cells with a magnetic payload can be sorted in
order to select the most effective population for therapeutic and
diagnostic purposes. Therefore we tested the possibility of
manipulating macrophages with an external magnetic field by
a cell sorting experiment carried out at 4 C with a magnetic trap
based on a NdFeB magnet (Fig. 5d). The cells separated by the
magnetic trap after 10 minutes and the cells not trapped by the
magnet were assayed by flow cytometry and the double fluores-
cence signal associated to MNPs and CD13 staining was quan-
titatively analyzed. We found that the 95% of the macrophages
were effectively captured by the magnetic trap after only 10
minutes of exposure (Fig. 5d). The flow cytometry shows that
lower fluorescence intensity in the fluorescein channel is
measured for non-sorted cells (Fig. S2 in the ESI†), in agreement
with the presence of a lower FeOx–MNPs payload in these cells.
These data show that macrophage cells loaded with fluorescent
FeOx–MNPs can be effectively sorted and manipulated by
means of a magnetic field.
Moreover, we investigated the cell viability and the presence of
apoptosis events after exposure to FeOx–MNPs. Macrophage
viability after FeOx–MNPs incorporation was assessed by theThis journal is ª The Royal Society of Chemistry 2011XTT assay that measures the activity of intracellular reductase
enzymes. U937 differentiated cells were incubated for 4 h at
37 C with FeOx–MNPs at a Fe concentration of 0.18, 0.36 and
0.72 mg ml1 and the cell viability was measured after 20 hours
analyzing XTT reduction with a microplate reader. As shown in
Fig. 6a, no influence of FeOx–MNPs on the cell viability was
evidenced by the XTT assay.
We also investigated the induction of apoptosis events in U937
differentiated cells exposed to FeOx–MNPs for 4 hours at a Fe
concentration of 0.36 mg ml1. Cells were analysed 2 hours and
20 hours after the removal of excess FeOx–MNPs by the human
Annexin V-FITC protocol that is specific for the phosphati-
dylserine expression on the outer leaflet of the cell membrane.
Flow cytometry analysis after 2 hours and after 20 hours
demonstrated that no apoptotic events were present (Fig. 6b–d).Conclusions
The synthesis of multifunctional magnetic nanoparticles is
a topic of great interest for nanomedicine applications. Here we
presented a new method for obtaining FeOx–MNPs in water
solution based on the Laser Ablation Synthesis in Solution
(LASiS). LASiS is a top-down ‘‘green’’ technique for obtaining
colloidal solutions of nanoparticles without chemicals and with
limited manual operation. A variety of complementary investi-
gation techniques were used for the characterization of our
FeOx–MNPs. The results indicated that FeOx–MNPs have
nanometric size, a polycrystalline structure composed preva-
lently of magnetite with a minor fraction of hematite and
a significant hydroxylation of interfaces. Magnetic character-
ization showed that FeOx–MNPs have a saturation magnetiza-
tion of ca. 80 emu g1, higher than values usually reported forJ. Mater. Chem.
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View OnlineMNPs with similar size and composition. The unusual magnetic
properties observed on our FeOx–MNPs can be ascribed to the
coexistence of ferrimagnetic (magnetite) and antiferromagnetic
(hematite) phases in the same polycrystalline structure. The
feasibility of functionalization and sequential multi-
functionalization of FeOx–MNPs with carboxylated phospho-
nates, fluorescent alkylamines, fluorescent isothiocyanates and
bovine serum albumin were demonstrated. In particular,
PMIDA and SDS resulted as excellent stabilizers of FeOx–
MNPs in physiological medium and can offer the opportunity
for further functionalization of particles surface. FeOx–MNPs
did not show any cytotoxic effect and do not induce apoptosis in
our experimental conditions. Fluorescent MNPs were used for
uptake and manipulation studies with macrophage cells. The
multifunctionality of FeOx–MNPs was exploited for detecting
the uptake in U937 macrophage cells by fluorescence microscopy
and by flow cytometry and for the quantitative assay of cell
sorted by a magnetic trap. In this way we obtained vehicles that
can autonomously transport theranostic agents into tissues or
lesions that are hardly reached by the haematic flux.
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